In addition, COX-2-mediated hypoxia in the TME, along with its positive interactions with YAP1 and anti-apoptotic factors, collectively contributes to cancer cell resistance to chemotherapeutic drugs.28 The gene discussed is PTGS2; the disease is cancer.